Fused ring-containing oxazolidinones antibiotics

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9487545
APP PUB NO 20140243288A1
SERIAL NO

14347595

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a fused ring-containing oxazolidinone compound shown by general formula (I), a pharmaceutically acceptable salt thereof and a stereoisomer thereof, wherein R1, R2, R3, R4, R5, R6, A, B and C are as defined in the description. The present invention further relates to a method for preparing the compound, a pharmaceutical composition and a pharmaceutical formulation comprising the compound, and a use of the compound for the manufacture of a medicament for the treatment and/or prevention of infectious diseases and a use for the treatment and/or prevention of infectious diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
XUANZHU PHARMA CO LTDTIANCHEN AVENUE HIGH TECH ZONE OF JI'NAN CITY SHANDONG PROVINCE NO 2518 250101 JINAN CITY SHANDONG PROVINCE 250101

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Wang, Aichen Shandong, CN 10 18
Zhang, Hui Shandong, CN 899 8264

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 8, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00